首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma
【24h】

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

机译:更新分析LCAR-B38M的阶段1,嵌合抗原受体T细胞疗法的阶段1,对B细胞成熟抗原的嵌合抗原受体T细胞疗法,复发/难治性多发性骨髓瘤患者

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
  • 作者单位

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Natl Local Joint Engn Res Ctr Biodiagnost &

    Bioth Affiliated Hosp 2 Xian;

    Xi An Jiao Tong Univ Natl Local Joint Engn Res Ctr Biodiagnost &

    Bioth Affiliated Hosp 2 Xian;

    Xi An Jiao Tong Univ Dept Clin Lab Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Clin Lab Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Nanjing Legend Biotech Nanjing Jiangsu Peoples R China;

    Nanjing Legend Biotech Nanjing Jiangsu Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

    Xi An Jiao Tong Univ Dept Hematol Affiliated Hosp 2 Xian Shaanxi Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 血液及淋巴系疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号